Global Leishmaniasis Treatment Market: Industry Analysis and Forecast (2020-2026) By Type, Pathological Tests, Drug Type, End-users and Region

Global Leishmaniasis Treatment Market is expected to grow at a CAGR of 8.4% during the forecast period. Global Leishmaniasis Treatment Market is expected to reach US$ 230 Mn. by 2026.

Global Leishmaniasis Treatment Market Overview:

Leishmaniasis is one of the neglected tropical diseases caused by different species of the protozoan parasite Leishmania. It is spread by the bite of certain types of sandflies and occurs most frequently in the tropics and sub-tropics of Africa, Asia, the Americas, and southern Europe. The disease can present in three main ways: cutaneous, mucosal, and visceral.

Global Leishmaniasis Treatment Market Dynamics:

Lack of hygiene and poor sanitation facilities in some rural areas are the main causes for the spread of Leishmaniasis and drives the market growth. Factors like the high prevalence of target diseases in some underdeveloped and developing nations, prevalence of malnutrition across the globe and migratory patterns of a population boost the demand for the Leishmaniasis Treatment market. According to the data of 2017, the World Health Organization (WHO) has stated that Leishmaniasis is one of the most neglected diseases, with 350 million people considered at risk of contracting the disease, with a burden of about 12 million people currently infected in 98 countries, and two million new cases estimated to occur annually. Besides this, an increase in R & D funding, introduction of new chemical entities, favourable government initiatives, and new development in the therapy area also create potential growth opportunities for the market growth. However, lack of awareness in some developing countries and long duration for treatment may hamper the market growth. The report has profiled Seventeen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.

Global Leishmaniasis Treatment Market Segment Analysis:

The Global Leishmaniasis Treatment Market is segmented on the basis of Type, Pathological Tests, Drug Type and End-Users. Based on Type, Cutaneous Leishmaniasis is expected to hold a dominant market share during the forecast period. This is the most common form of leishmaniasis, both in general and in U.S. travellers. Cutaneous Leishmaniasis causes skin lesions, which can persist for months, sometimes years. About 1.5 million new cases of cutaneous leishmaniasis and 500 000 new cases of visceral leishmaniasis occur each year around the world. Based on Pathological Tests, Serological Tests held a dominant share of XX% in 2019. The segment is expected to grow due to the surge in demand for pathological testing for the diagnosis of various infectious diseases. Leishmaniasis is also linked to environmental changes such as deforestation, the building of dams, irrigation schemes, and urbanization.

Recent Developments:

• According to the news released in March 2020, Novartis and the Drugs for Neglected Diseases initiative signed a collaboration and license agreement to jointly develop LXE408, as a potential new oral treatment for visceral leishmaniasis, one of the world's leading parasitic killers. • Gilead science signed an agreement with WHO in 2016, to donate 445,000 vials of AmBisome to the World Health Organization for the tenure of 5 years which is a leading brand being used for the treatment of leishmaniasis. Global Leishmaniasis Treatment Market To know about the Research Methodology :- Request Free Sample Report

Global Leishmaniasis Treatment Market Regional Insights:

 Global Leishmaniasis Treatment Market Regional Insights

North America held a dominant market share in 2019.

The region is expected to continue the dominance throughout the forecast period. The region is experiencing lucrative growth owing to factors such as the prevalence of sedentary and unhealthy lifestyle, a high number of target diseases, rise in FDA approval for products, ongoing clinical trials and presence of favourable government policies. These factors create the potential for market growth in the region. The report also helps in understanding the Global Leishmaniasis Treatment Market dynamics, structure by analyzing the market segments and project the Global Leishmaniasis Treatment Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Leishmaniasis Treatment Market make the report investor’s guide.

Global Leishmaniasis Treatment Market Scope: Inquire before buying

Global Leishmaniasis Treatment Market

Global Leishmaniasis Treatment Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Leishmaniasis Treatment Market Key Players

• Sequus Pharmaceuticals Inc. • Novartis • Gland Pharma Limited • Paladin Labs Inc. • Sanofi S.A. • Gilead Life sciences • Lifecare Innovations Private Limited • Enzon Pharmaceuticals Inc. • Profounda, Inc. • Merck • iCo Therapeutics • AEterna Zentaris • Eurofins Advinus • Pieris Pharmaceuticals • GloxoSmithKline • Pfizer • Jassen Pharmaceutical
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Leishmaniasis Treatment Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Leishmaniasis Treatment Market 3.4. Geographical Snapshot of the Leishmaniasis Treatment Market, By Manufacturer share 4. Global Leishmaniasis Treatment Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Leishmaniasis Treatment Market 5. Supply Side and Demand Side Indicators 6. Global Leishmaniasis Treatment Market Analysis and Forecast, 2019-2026 6.1. Global Leishmaniasis Treatment Market Size & Y-o-Y Growth Analysis. 7. Global Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 7.1.1. Cutaneous Leishmaniasis 7.1.2. Mucosal Leishmaniasis 7.1.3. Visceral Leishmaniasis y 7.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 7.2.1. Serological Tests 7.2.2. Parasitological Evaluation 7.2.3. DNA-based Methods 7.2.4. Immunological Methods 7.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 7.3.1. Pentavalent Antimonials 7.3.2. Antibiotics 7.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 7.4.1. Clinics 7.4.2. Hospitals 7.4.3. Diagnostic Laboratory 7.4.4. Others 8. Global Leishmaniasis Treatment Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 9.1.1. Cutaneous Leishmaniasis 9.1.2. Mucosal Leishmaniasis 9.1.3. Visceral Leishmaniasis 9.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 9.2.1. Serological Tests 9.2.2. Parasitological Evaluation 9.2.3. DNA-based Methods 9.2.4. Immunological Methods 9.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 9.3.1. Pentavalent Antimonials 9.3.2. Antibiotics 9.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 9.4.1. Clinics 9.4.2. Hospitals 9.4.3. Diagnostic Laboratory 9.4.4. Others 10. North America Leishmaniasis Treatment Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 11.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 12. Canada Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 12.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 13. Mexico Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 13.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 14. Europe Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 14.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 15. Europe Leishmaniasis Treatment Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 16.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 17. France Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 17.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 18. Germany Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 18.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 19. Italy Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 19.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 20. Spain Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 20.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 21. Sweden Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 21.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 22. CIS Countries Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 22.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 23. Rest of Europe Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 23.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 24. Asia Pacific Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 24.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 25. Asia Pacific Leishmaniasis Treatment Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 26.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 27. India Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 27.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 28. Japan Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 28.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 29. South Korea Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 29.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 30. Australia Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 30.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 31. ASEAN Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 31.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 32. Rest of Asia Pacific Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 32.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 33. Middle East Africa Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 33.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 34. Middle East Africa Leishmaniasis Treatment Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 35.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 36. GCC Countries Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 36.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 37. Egypt Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 37.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 38. Nigeria Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 38.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 39. Rest of ME&A Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 39.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 40. South America Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 40.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 41. South America Leishmaniasis Treatment Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 42.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 43. Argentina Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 43.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 44. Rest of South America Leishmaniasis Treatment Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Pathological Tests, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By Drug Type, 2019-2026 44.4. Market Size (Value) Estimates & Forecast By End users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Leishmaniasis Treatment Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Sequus Pharmaceuticals Inc.. 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Novartis 45.3.3. Gland Pharma Limited 45.3.4. Paladin Labs Inc. 45.3.5. Sanofi S.A. 45.3.6. Gilead Life sciences 45.3.7. Lifecare Innovations Private Limited 45.3.8. Enzon Pharmaceuticals Inc. 45.3.9. Profounda, Inc. 45.3.10. Merck 45.3.11. iCo Therapeutics 45.3.12. AEterna Zentaris 45.3.13. Eurofins Advinus 45.3.14. Pieris Pharmaceuticals 45.3.15. GlaxoSmithKline 45.3.16. Pfizer 45.3.17. Jassen Pharmaceutical 46. Primary Key Insights

About This Report

Report ID 93529
Category Healthcare
Published Date April 2021
Updated Date Nov 2021
Contact Us